Stress Proteins as Inducers and Targets of Regulatory T Cells in Arthritis

REFERENCES

• R.J. Ellis, The molecular chaperone concept, Semin. Cell. Biol., 1: 1–9, 1990.
   PubMedGoogle Scholar
• W.J. Welch, How cells respond to stress, Sci. Am., 268: 56–64, 1993.
   PubMedGoogle Scholar
• L. Mizzen, Immune responses to stress proteins: applications to infectious disease and cancer. Biotherapy, 10: 173–189, 1998. [CSA]
   PubMedGoogle Scholar
• J.S. Gaston, Heat shock proteins and arthritis—new readers start here, Autoimmunity, 26: 33–42, 1997. [CSA]
   PubMed Web of Science ®Google Scholar
• A. De Maio, Heat shock proteins: facts, thoughts, and dreams, Shock, 11: 1–12, 1999.
   PubMed Web of Science ®Google Scholar
• D. Przepiorka and P.K. Srivastava, Heat shock protein–peptide complexes as immunotherapy for human cancer, Mol. Med. Today, 4: 478–84, 1998. [CSA], [CROSSREF]
   PubMedGoogle Scholar
• R.M. Vabulas, P. Ahmad-Nejad, C. da Costa, T. Miethke, C.J. Kirschning, H. Hacker, and H. Wagner, Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells, J. Biol. Chem., 276: 31332–9, 2001. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• R.M. Vabulas, P. Ahmad-Nejad, S. Ghose, C.J. Kirschning, R.D. lssels, and H. Wagner, HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway, J. Biol. Chem., 277: 15107–12, 2002. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• K. Ohashi, V. Burkart, S. Flohe, and H. Kolb, Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex, J. Immunol., 164: 558–61, 2000.
   PubMed Web of Science ®Google Scholar
• W. Chen, U. Syldath, K. Bellmann, V. Burkart, and H. Kolb, Human 60-kDa heat-shock protein: a danger signal to the innate immune system, J. Immunol., 162: 3212–9, 1999.
   PubMed Web of Science ®Google Scholar
• P. Matzinger, Tolerance, danger, and the extended family, Annu. Rev. Immunol., 12: 991–1045, 1994. [CSA]
   PubMed Web of Science ®Google Scholar
• R. Suto and P.K. Srivastava, A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides, Science, 269: 1585–8, 1995.
   PubMed Web of Science ®Google Scholar
• R.J. Binder, K.M. Anderson, S. Basu, and P.K. Srivastava, Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c + cells in vivo, J. Immunol., 165: 6029–35, 2000.
   PubMed Web of Science ®Google Scholar
• I.R. Cohen, Kadishman's tree, Escher's angels, and the immunological homunculus, Isr. J. Med. Sci., 32: 44–50, 1996. [CSA]
   Google Scholar
• W. van Eden, J.E. Thole, R. van der Zee, A. Noordzij, J.D. van Embden, E.J. Hensen, and I.R. Cohen, Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis, Nature, 331: 171–3, 1988. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• W. van Eden, Heat-shock proteins as immunogenic bacterial antigens with the potential to induce and regulate autoimmune arthritis, Immunol. Rev., 121: 5–28, 1991.
   PubMed Web of Science ®Google Scholar
• R. Ulmansky, C.J. Cohen, F. Szafer, E. Moallem, Z.G. Fridlender, Y. Kashi, and Y. Naparstek, Resistance to adjuvant arthritis is due to protective antibodies against heat shock protein surface epitopes and the induction of IL-10 secretion, J. Immunol., 168: 6463–9, 2002.
   PubMedGoogle Scholar
• A. Bloemendal, R. Van der Zee, V.P. Rutten, P.J. van Kooten, J.C. Farine, and W. van Eden, Experimental immunization with anti-rheumatic bacterial extract OM-89 induces T cell responses to heat shock protein (hsp)60 and hsp70; modulation of peripheral immunological tolerance as its possible mode of action in the treatment of rheumatoid arthritis (RA), Clin. Exp. Immunol., 110: 72–8, 1997. [CSA], [CROSSREF]
   PubMedGoogle Scholar
• P.M. Cobelens, C.J. Heijnen, E.E. Nieuwenhuis, P.P. Kramer, R. van der Zee, W. van Eden, and A. Kavelaars, Treatment of adjuvant-induced arthritis by oral administration of mycobacterial Hsp65 during disease, Arthritis. Rheum., 43: 2694–702, 2000. [CROSSREF]
   PubMedGoogle Scholar
• P.M. Cobelens, A. Kavelaars, A. Vroon, M. Ringeling, R. van der Zee, W. van Eden, and C.J. Heijnen, The beta(2)-adrenergic agonist salbutamol potentiates oral induction of tolerance, suppressing adjuvant arthritis and antigen-specific immunity, J. Immunol., 169: 5028–35, 2002.
   Google Scholar
• S.M. Anderton, R. van der Zee, A. Noordzij, and W. van Eden, Differential mycobacterial 65-kDa heat shock protein T cell epitope recognition after adjuvant arthritis-inducing or protective immunization protocols, J. Immunol., 152: 3656–64, 1994.
   PubMed Web of Science ®Google Scholar
• S.M. Anderton, R. van der Zee, B. Prakken, A. Noordzij, and W. van Eden, Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis, J. Exp. Med., 181: 943–52, 1995. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• U. Wendling, L. Paul, R. van der Zee, B. Prakken, M. Singh, and W. van Eden, A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue, J. Immunol., 164: 2711–7, 2000.
   PubMed Web of Science ®Google Scholar
• A.G. Paul, R. van Der Zee, L.S. Taams, and W. van Eden, A self-hsp60 peptide acts as a partial agonist inducing expression of B7-2 on mycobacterial hsp60-specific T cells: a possible mechanism for inhibitory T cell regulation of adjuvant arthritis? Int. Immunol., 12: 1041–50, 2000. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• W. van Eden, R. van der Zee, A.G. Paul, B.J. Prakken, U. Wendling, S.M. Anderton, and M.H. Wauben, Do heat shock proteins control the balance of T-cell regulation in inflammatory diseases? Immunol. Today, 19: 303–7, 1998. [CSA], [CROSSREF]
   PubMedGoogle Scholar
• A.G. Paul, P.J. van Kooten, W. van Eden, and R. van der Zee, Highly autoproliferative T cells specific for 60-kDa heat shock protein produce IL-4/IL-10 and IFN-gamma and are protective in adjuvant arthritis, J. Immunol., 165: 7270–7, 2000.
   PubMed Web of Science ®Google Scholar
• L.S. Taams, A.J. van Rensen, M.C. Poelen, C.A. van Els, A.C. Besseling, J.P. Wagenaar, W. van Eden, and M.H. Wauben, Anergic T cells actively suppress T cell responses via the antigen-presenting cell, Eur. J. Immunol., 28: 2902–12, 1998. [CSA], [CROSSREF]
   Web of Science ®Google Scholar
• L.S. Taams, W. van Eden, and M.H. Wauben, Dose-dependent induction of distinct anergic phenotypes: multiple levels of T cell anergy, J. Immunol., 162: 1974–81, 1999.
   Google Scholar
• J.G. Chai, I. Bartok, P. Chandler, S. Vendetti, A. Antoniou, J. Dyson, and R. Lechler, Anergic T cells act as suppressor cells in vitro and in vivo, Eur. J. Immunol., 29: 686–92, 1999. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M. Wills-Karp, J. Santeliz, and C.L. Karp, The germless theory of allergic disease: revisiting the hygiene hypothesis, Nat. Rev. Immunol., 1: 69–75, 2001. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A.H. van den Biggelaar, R. van Ree, L.C. Rodrigues, B. Lell, A.M. Deelder, P.G. Kremsner, and M. Yazdanbakhsh, Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10, Lancet, 356: 1723–7, 2000. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Y. Yi, X. Yang, and R.C. Brunham, Autoimmunity to heat shock protein 60 and antigen-specific production of interleukin-10, Infect Immun., 65: 1669–74, 1997. [CSA]
   Google Scholar
• Y. Kimura, K. Yamada, T. Sakai, K. Mishima, H. Nishimura, Y. Matsumoto, M. Singh, and Y. Yoshikai, The regulatory role of heat shock protein 70-reactive CD4+ T cells during rat listeriosis, Int. Immunol., 10: 117–30, 1998. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• P. Stordeur and M. Goldman, Interleukin-10 as a regulatory cytokine induced by cellular stress: molecular aspects, Int. Rev. Immunol., 16: 501–22, 1998. [CSA]
   PubMedGoogle Scholar
• A.G. van Halteren, B. Mosselman, B.O. Roep, W. van Eden, A. Cooke, G. Kraal, and M.H. Wauben, T cell reactivity to heat shock protein 60 in diabetes-susceptible and genetically protected nonobese diabetic mice is associated with a protective cytokine profile, J. Immunol., 165: 5544–51, 2000.
   Google Scholar
• U. Wendling, L. Paul, R. van Der Zee, B. Prakken, M. Singh, and W. van Eden, A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue, J. Immunol., 164: 2711–2717, 2000.
   PubMed Web of Science ®Google Scholar
• B.J. Prakken, U. Wendling, R. van der Zee, V.P. Rutten, W. Kuis, and W. van Eden, Induction of IL-10 and inhibition of experimental arthritis are specific features of microbial heat shock proteins that are absent for other evolutionarily conserved immunodominant proteins, J. Immunol., 167: 4147–53, 2001.
   PubMed Web of Science ®Google Scholar
• B.J. Prakken, S. Roord, P.J. van Kooten, J.P. Wagenaar, W. van Eden, S. Albani, and M.H. Wauben, Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60T cell epitope, Arthritis Rheum., 46: 1937–46, 2002. [CROSSREF]
   PubMedGoogle Scholar
• P. Woo and L.R. Wedderburn, Juvenile chronic arthritis, Lancet, 351: 969–73, 1998.
   PubMed Web of Science ®Google Scholar
• I.M. de Kleer, L.R. Wedderburn, L.S. Taams, A. Patel, H. Varsani, M. Klein, W. de Jager, G. Pugayung, F. Giannoni, G. Rijkers, S. Albani, W. Kuis, and B. Prakken, CD4 + CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis, J. Immunol., 172: 6435–43, 2004.
   PubMed Web of Science ®Google Scholar
• B. Prakken, W. Kuis, W. Van Eden, and S. Albani, Heat shock proteins in juvenile idiopathic arthritis: keys for understanding remitting arthritis and candidate antigens for immune therapy, Curr. Rheumatol. Rep., 4: 466–73, 2002. [CSA]
   PubMedGoogle Scholar
• C.J. Boog, E.R. de Graeff-Meeder, M.A. Lucassen, R. van der Zee, M.M. Voorhorst-Ogink, P.J. van Kooten, H.J. Geuze, and W. van Eden, Two monoclonal antibodies generated against human hsp60 show reactivity with synovial membranes of patients with juvenile chronic arthritis, J. Exp. Med., 175: 1805–10, 1992. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• E.R. de Graeff-Meeder, G.T. Rijkers, M.M. Voorhorst-Ogink, W. Kuis, R. van der Zee, W. van Eden, and B.J. Zegers, Antibodies to human HSP60 in patients with juvenile chronic arthritis, diabetes mellitus, and cystic fibrosis, Pediatr. Res., 34: 424–8, 1993.
   PubMed Web of Science ®Google Scholar
• E.R. De Graeff-Meeder, R. van der Zee, G.T. Rijkers, H.J. Schuurman, W. Kuis, J.W. Bijlsma, B.J. Zegers, and W. van Eden, Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis, Lancet, 337: 1368–72, 1991. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• P. Life, A. Hassell, K. Williams, S. Young, P. Bacon, T. Southwood, and J.S. Gaston, Responses to gram negative enteric bacterial antigens by synovial T cells from patients with juvenile chronic arthritis: recognition of heat shock protein HSP60, J. Rheumatol., 20: 1388–96, 1993.
   PubMed Web of Science ®Google Scholar
• E.R. de Graeff-Meeder, W. van Eden, G.T. Rijkers, B.J. Prakken, W. Kuis, M.M. Voorhorst-Ogink, R. van der Zee, H.J. Schuurman, P.J. Helders, and B.J. Zegers, Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis, J. Clin. Invest., 95: 934–40, 1995. [CSA]
   PubMed Web of Science ®Google Scholar
• I.M. de Kleer, S.M. Kampuis, G.T. Rijkers, L. Scholtens, G. Gordon, W. De Jager, R. Hafner, R. van de Zee, W. van Eden, W. Kuis, and B.J. Prakken, The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30 + T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10, Arthritis Rheum, 48: 2001–10, 2003. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• F.J. Quintana, P. Carmi, F. Mor, and I.R. Cohen, Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60, J. Immunol., 169: 3422–8, 2002.
   PubMed Web of Science ®Google Scholar
• B. Prakken, M. Wauben, D. Genini, R. Samodal, J. Barnett, A. Mendivil, L. Leoni, and S. Albani, Artificial antigen-presenting cells as a tool to exploit the immune ‘synapse’, Nat. Med., 6: 1406–10, 2000. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A.B. Prakken, M.J. van Hoeji, W. Kuis, A. Kavelaars, C.J. Heynen, E. Scholtens, I.M. de Kleer, G.T. Rijkers, and W. van Eden, T-cell reactivity to human HSP60 in oligo-articular juvenile chronic arthritis is associated with a favorable prognosis and the generation of regulatory cytokines in the inflamed joint, Immunol. Lett., 57: 139–42, 1997. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S. Sakaguchi, N. Sakaguchi, J. Shimizu, S. Yamazaki, T. Sakihama, M. ltoh, Y. Kuniyasu, T. Nomura, M. Toda, and T. Takahashi, Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance, Immunol. Rev., 182: 18–32, 2001. [CSA]
   PubMed Web of Science ®Google Scholar
• E.M. Shevach, R.S. McHugh, C.A. Piccirillo, and A.M. Thornton, Control of T-cell activation by CD4+ CD25+ suppressor T cells, Immunol. Rev., 182: 58–67, 2001. [CSA]
   PubMed Web of Science ®Google Scholar
• L.A. Stephens, C. Mottet, D. Mason, and F. Powrie, Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro, Eur. J. Immunol., 31: 1247–54, 2001. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• L.S. Taams, J. Smith, M.H. Rustin, M. Salmon, L.W. Poulter, and A.N. Akbar, Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population, Eur. J. Immunol., 31: 1122–31, 2001. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• T. Takahashi, Y. Kuniyasu, M. Toda, N. Sakaguchi, M. ltoh, M. lwata, J. Shimizu, and S. Sakaguchi, Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state, Int. Immunol., 10: 1969–80, 1998. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• L.S. Taams, M. Vukmanovic-Stejic, J. Smith, P.J. Dunne, J.M. Fletcher, F.J. Plunkett, S.B. Ebeling, G. Lombardi, M.H. Rustin, J.W. Bijlsma, F.P. Lafeber, M. Salmon, and A.N. Akbar, Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells, Eur. J. Immunol., 32: 1621–30, 2002. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• R.S. McHugh, M.J. Whitters, C.A. Piccirillo, D.A. Young, E.M. Shevach, M. Collins, and M.C. Byrne, CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor, Immunity, 16: 311–23, 2002. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• newpage pagenumber="197"/>, J. Shimizu, S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi, Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance, Nat. Immunol., 2002.
   Google Scholar
• O. Annacker, R. Pimenta-Araujo, O. Burlen-Defranoux, T.C. Barbosa, A. Cumano, and A. Bandeira, CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10, J. Immunol., 166: 3008–18, 2001.
   PubMed Web of Science ®Google Scholar
• M. Papiernik, Natural CD4+ CD25+ regulatory T cells. Their role in the control of superantigen responses, Immunol. Rev., 182: 180–9, 2001. [CSA], [CROSSREF]
   Google Scholar